Sanofi’s Venglustat Gets Breakthrough Therapy Status in US
Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to venglustat, a novel,...